Clinical Trial Update: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating aztreonam for inhalation solution (AZLI) in cystic fibrosis patients with Pseudomonas aeruginosa completed, with safety and ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2011-03-11